Lord, Abbett & Co
CDMO

Lord, Abbett & Co’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Lord, Abbett & Co’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-544,300
Closed -$6.19M – 597
2024
Q3 		$6.19M Buy
+544,300
New +$5.46M 0.02% 456

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Lord, Abbett & Co's CDMO Position: Q4 2024 in Review

Lord, Abbett & Co sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 544,300 shares — an estimated $6.19M sold.

Lord, Abbett & Co first reported a position in CDMO in Q3 2024 and held it in 1 quarter. The position peaked at $6.19M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Lord, Abbett & Co reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 544,300 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $6.19M.
  • Lord, Abbett & Co first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Lord, Abbett & Co's Avid Bioservices, Inc. Common Stock position peaked at $6.19M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Lord, Abbett & Co's 13F filing for Q4 2024, filed 14 Feb 2025.